Tech Company Financing Transactions

Crinetics Pharmaceuticals Funding Round

Perceptive Advisors, 5AM Ventures and OrbiMed participated in a $63.5 million Series B funding round for Crinetics Pharmaceuticals. The round was announced by the company on 3/15/2018.

Transaction Overview

Company Information

Company Status

Publicly-held

Industry

Biopharmaceutical

Mailing Address

10222 Barnes Canyon Rd. Building #2
San Diego, CA 92121
USA

Phone

(858) 450-6464

Website

www.crinetics.com

Email Address

[email protected]

Overview

Crinetics Pharmaceuticals (Nasdaq: CRNX) discovers and develops novel therapeutics targeting peptide hormone receptors for the treatment of endocrine-related diseases and cancers.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Scott Struthers

        

Chief Financial Officer

Marc Wilson

        

Vice President

Stephen Betz

        

Vice President

Yun-Fei Zhu

        

VP - Bus. Development

Ajay Madan

        

Browse more venture capital transactions:

Prev: 3/15/2018: Finally Light Bulb venture capital transaction
Next: 3/15/2018: STAQ venture capital transaction

Share this article

About Our VC Transactions Data

We record all VC transactions involving tech companies. VC investment data records reported here come from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary